EVENTIDE ASSET MANAGEMENT, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Celldex Therapeutics, Inc. Common Stock, par value $0.001 (CLDX)

Filing Manager
EVENTIDE ASSET MANAGEMENT, LLC
Reporting Manager
Eventide Asset Management, LLC
Security
Celldex Therapeutics, Inc. Common Stock, par value $0.001
Symbol
CLDX
Shares outstanding
67,809,300 shares
Disclosed Ownership
1,356,186 shares
Ownership
2%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 14:59:36 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Eventide Asset Management, LLC 2% 1,356,186 1,356,186 0 /s/ Peter J. Luiso Peter J. Luiso, General Counsel
Finny Kuruvilla, M.D. Ph. D. 2% 1,356,186 0 1,356,186 /s/ Finny Kuruvilla, M.D., Ph. D. Finny Kuruvilla, M.D., Ph. D.
Robin C. John 2% 1,356,186 0 1,356,186 /s/ Robin C. John Robin C. John